Interview: Maria Queiroz – Founder and CEO, Eurotrials, Portugal

Eurotrials is a full-service contract research organization (CRO) with an international footprint in over five territories worlwide. Following the trend of big pharma, Eurotrials recently merged with CTI, an American privately owned clinical trial and consulting service. Maria Queiroz founded the company in 1995 with Inês Costa, and here puts forward Portugal’s strengths in clinical research, the need to create scope and internationalize from Portugal, and Eurotrials’ evolution since their founding 23 years ago. What strengths does Portugal display in the healthcare and life sciences sector?
"Historically, clinical research has maintained a particularly high quality in Portugal. Moreover, in the last ten years, despite the economic restraints and the squeeze we have felt across the industry, research institutes have managed to continue their own research independently."
Become a PharmaBoardroom Member for free to access this content
Join the 35,000+ pharmaceutical professionals who already subscribe to PharmaBoardroom
Already a member? Sign In

Related Interviews

Latest Report